Top Markets
#1 Cortex Cortex +32.65%
#2 龙虾 (Lobster) 龙虾 (Lobster) +24.80%
#3 DexNet DexNet +23.20%
#4 Akedo Akedo +23.04%
#5 wojak wojak +17.37%
#6 Pons Pons +16.92%
#7 OpenEden OpenEden +12.43%
#8 Official Trump Official Trump +10.98%
#9 MarsCoin MarsCoin +10.26%
#10 EXOD EXOD +9.04%
Coin of the day
Cortex Cortex
Settings
Language
ENGLISH
Currency
USD
Theme
HBM Holdings Limited HBM Holdings Limited

HBM Holdings Limited

2142
Rank in Stocks #7239
HBM Holdings Limited is a clinical-stage biopharmaceutical enterprise focused... HBM Holdings Limited is a clinical-stage biopharmaceutical enterprise focused on identifying and developing unique antibody-based treatments for a variety of immunological conditions and cancers. The company's pipeline includes several promising assets. In immunology, Batoclimab (HBM9161) is a human monoclonal antibody specifically designed to bind and inhibit the neonatal fragment crystallizable receptor, while Tanfanercept (HBM9036) is under development to address moderate to severe dry eye disease. For oncology, HBM Holdings is advancing various therapies, such as HBM7008, a bispecific antibody targeting tumor-associated antigens, and HBM4003, a human anti-CTLA-4 antibody. Additional cancer candidates in their portfolio include HBM9302 for breast and gastric cancers, HBM7020 for multiple myeloma, and a suite of treatments—HBM1007, HBM1029, HBM7015, HBM7008, and HBM1022—geared towards solid tumors. Furthermore, HBM9022 is being developed to treat SARS-COV-2. Operating globally, HBM Holdings has a presence in Mainland China, the United States, Europe, and other international markets. The company also fosters strategic partnerships for antibody-drug conjugate (ADC) projects with LegoChem Biosciences Inc. and Duality Biotherapeutics, Inc. HBM Holdings Limited was founded in 2016 and is based in Shanghai, People's Republic of China.
Share Price
$1.99
Market Cap
$1.67B
Change (1 day)
-4.66%
Change (1 year)
22.01%
Country
CN
Trade HBM Holdings Limited (2142)

Category

Healthcare
Dividend history for HBM Holdings Limited (2142)
HBM Holdings Limited (stock symbol: 2142) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for HBM Holdings Limited (2142) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH